ClinicalTrials.gg
Status unknownNCT05438745PawamedicsUpdated Jun 30, 2022

The Effects of Dog Therapy on Ambulance Staff Burnout Scores.

An observational study in Burn Out and EMS Exposures or Injuries of EMS Personnel, sponsored by Yorkshire Ambulance Service NHS Trust. Status unknown. Open to participants aged 18 Years to 68 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-06-30.

Sponsored by Yorkshire Ambulance Service NHS Trust · Observational

The sponsor has not verified this record recently (last verified Jun 2022), so the status shown — last known as Not yet recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
20
Ages
18 Years to 68 Years
Sex
All
01

Study summary

Problem During the COVID 19 pandemic, NHS staff have become increasingly burned out. Mental health is the leading cause of staff sickness and absence in the NHS. Ambulance trusts have the highest rates of sickness across all NHS professions. Reduced staffing levels directly impacts service delivery. Staff struggling with poor mental health are more likely to make errors, have reduced empathy, and patients have lower patient satisfaction.

The Solution? Dog therapy is used in hospital settings around the world for patient benefit and staff welfare.

Evidence suggests dog therapy improves mood and reduces anxiety. Yorkshire Ambulance Service (YAS) has a small, but established dog therapy scheme, organised by the health and wellbeing team.

This research aims to observe if dog therapy affects symptoms of burnout in YAS staff. We will use two sets of staff:

Patient facing staff Staff with remote patient contact

What will participants need to do?

Participants will be given a Copenhagen Burnout Inventory - a questionnaire focusing on three factors:

Personal burnout Work related burnout Client related burnout

Burnout will be measured in 4 categories; no/low, moderate, high and severe burnout.

The questionnaire will be completed at the beginning and end of 8 weeks of dog therapy.

  • Some optional demographic questions
  • Number of sessions attended
  • Engagement with occupational health services
  • Dog Ownership

We will calculate the difference in severity of burnout between baseline and after 8 weeks of dog therapy.

A PPI group has been consulted on methodology, wording of plain English summary and the dissemination plan.

This research will be distributed to all interested participants, published in an appropriate journal presented at conferences, and presented in the ICA dissemination event.

02

Conditions studied

  • Burn Out
  • EMS Exposures or Injuries of EMS Personnel
03

In context

Burnout, Psychological

467 studies on the registry are indexed under Burnout, Psychological; 121 are open to participants now.

This study's planned enrollment of 20 is below the median of 200 across 117 observational studies indexed under Burnout, Psychological.

Browse Burnout, Psychological studies →

Lead sponsor

Yorkshire Ambulance Service NHS Trust is the lead sponsor of 6 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 68 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Convenience sample of patient facing staff who are participating in Yorkshire Ambulance Service pet therapy scheme.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Yorkshire Ambulance Service (YAS) Employee with patient contact. Patient contact includes face to face to face or remote patient contact. Taking part in YAS dog therapy scheme. Completed no more than 2 dog therapy sessions to date. -

Exclusion criteria

Exclusion Criteria:

Staff with no patient contact as part of their role. Staff on bank contract

-

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
20 participants (estimated)
Patient registry
No

Groups and cohorts

  • Experimental Group

    Ambulance Service Staff participating in pet therapy sessions.

    Other: Copenhagen Burnout Inventry

Interventions

  • OtherCopenhagen Burnout Inventry

    Questionnaire

06

What researchers measure

Primary outcomes

  1. Mean difference in change of each section of Copenhagen Burnout Inventory (CBI) Score

    CBI will be measured at week 0 and week 8. The CBI is composed of 3 sections. We will calculate a mean change in score for each of the 3 sections.

    Time frame: 8 weeks.

Secondary outcomes

  1. Mean difference ambulance turnaround times.

    We will calculate a mean difference in ambulance turnaround times for those participating in dog therapy vs those not participating on dog therapy.

    Time frame: 8 weeks.

  2. Drop out rate.

    We will report the proportion of participants that withdraw from the study.

    Time frame: 8 weeks.

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Aug 2022; primary completion for Sep 2022, 1 month later.

Of 34 non-industry observational studies under Burnout, Psychological, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 28. This study's planned 1 month is below that.

Counting every sponsor, half of 37 studies reached it within 10 months; a quarter within 5 and three quarters within 28.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 24, 2022
First posted
Jun 30, 2022
StartEst.
Aug 1, 2022
Primary completionEst.
Sep 30, 2022
CompletionEst.
Sep 30, 2022
Last update
Jun 30, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 30, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05438745
Lead sponsor
Yorkshire Ambulance Service NHS Trust
Collaborators
National Institute for Health Research, United Kingdom
Responsible party
Sponsor
First posted
Jun 30, 2022
Start date
Aug 1, 2022 (estimated)
Primary completion
Sep 30, 2022 (estimated)
Completion
Sep 30, 2022 (estimated)
Last update
Jun 30, 2022

Study contacts

Richard Pilbery, MSc
Contact
r.pilbery@nhs.net
+44‭07592269779‬
Richard Pilbery, MSc
principal investigator · Yorkshire Ambulance Service NHS Trust

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jun 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion